Teva- Pharmaceutical Industries Ltd. ADR’s recently made public that its Officer Jover Placid acquired Company’s shares for reported $91748.0 on Aug 01 ’25. In the deal valued at $15.16 per share,6,053 shares were bought.
Then, Hughes Eric A bought 52,742 shares, generating $799,437 in total proceeds.
Before that, Kalif Eliyahu Sharon sold 55,775 shares. Teva- Pharmaceutical Industries Ltd. ADR shares valued at $952,464 were divested by the EVP, Chief Financial Officer at a price of $17.08 per share. As a result of the transaction, Kalif Eliyahu Sharon now holds 403,288 shares, worth roughly $6.2 million.
Goldman initiated its Teva- Pharmaceutical Industries Ltd. ADR [TEVA] rating to a Buy in a research note published on June 06, 2025; the price target was $24. A number of analysts have revised their coverage, including Truist’s analysts, who began to cover the stock in late May with a ‘”a Buy”‘ rating. JP Morgan also remained covering TEVA and has increased its forecast on May 12, 2025 with a “an Overweight” recommendation from previously “Neutral” rating. Argus revised its rating on July 10, 2024. It rated TEVA as “a Buy” which previously was an “a Hold”.
Price Performance Review of TEVA
On Friday, Teva- Pharmaceutical Industries Ltd. ADR [NYSE:TEVA] saw its stock fall -0.45% to $15.38. Over the last five days, the stock has lost -7.01%. Teva- Pharmaceutical Industries Ltd. ADR shares have fallen nearly -6.28% since the year began. Nevertheless, the stocks have fallen -30.22% over the past one year.
How much short interest is there in Teva- Pharmaceutical Industries Ltd. ADR?
A steep rise in short interest was recorded in Teva- Pharmaceutical Industries Ltd. ADR stocks on 2025-07-15, growing by 13.43 million shares to a total of 53.42 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 40.0 million shares. There was a rise of 25.13%, which implies that there is a positive sentiment for the stock.
